These synthetic receptor antagonists inhibited EAE by interfering with the action of CXCR3 and CXCR4 in a mouse model of multiple sclerosis called experimental autoimmune encephalomyelitis (EAE). The gene discussed is CXCR4; the disease is multiple sclerosis.